title: [Supracricoid partial laryngectomy with CHP and CHEP for local recurrence following irradiation of vocal cord carcinoma].
abstract: The cases of CHEP and CHP following supracricoid partial laryngectomy in the treatment of the local recurrence after irradiation of vocal cord carcinoma were reported. In both cases the wound was healed by first intention. The cannula was not removed in the patient after CHEP, although the wide of neolarynx and spirometry parameters showed such a possibility. That patient with a huge obesity developed progressive coronary disease after surgery. Sometimes he needs to open the plugged cannula. The spirometry parameters confirmed that the patient after CHP could be decannulationed in the third month after surgery. Because of his psychological resistance that was delayed to the sixth month. The deglutition is efficient in both patients. The oesophagus tube was removed in sixth and seventh weeks after the operation. The patient after CHEP was carried out the objective evaluation of deglutition in the videoroentgenokinematography which showed a small aspiration. In spite of that he didn't develop any pulmonary complication during 2.5 years after surgery. A few cases and short time of observation doesn't allowed us to draw the objective conclusions to the presented question.
authors.affiliation: Katedra i Klinika Otolaryngologii i Onkologii Laryngologicznej PAM w Szczecinie.
authors.forename: Eugeniusz
authors.initials: E
authors.lastname: Zietek
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Firlit
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000601:surgery*; D003413:Cricoid Cartilage / Q000601:surgery*; D003679:Deglutition; D004825:Epiglottis / Q000601:surgery*; D006801:Humans; D006928:Hyoid Bone / Q000601:surgery*; D007822:Laryngeal Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D016879:Salvage Therapy; D016896:Treatment Outcome